Drug Abuse Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Drug Abuse Testing Market is Segmented by Product Type (Analyzers [Immunoassay Analyzers, Chromatographic Devices, and Breath Analyzers], Rapid Testing Devices [Urine Testing Devices and Oral Fluid Testing Devices], and Consumables), Sample Type (Saliva, Urine, Blood, and Other Sample Types), End User (Hospitals, Diagnostic Laboratories, Forensic Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (USD million) for all the above segments.

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The drug abuse testing market is expected to register a CAGR of 7.5% over the forecast period, 2021-2026.

The impact of the COVID-19 pandemic on the market is expected to be significant. According to the research article published in Frontiers in Psychiatry, 2020, forced isolation and quarantine during COVID-19 can impact the behavior of drug abusers. Also, due to the stringent lockdown measures and social distancing to combat the coronavirus spread, an increase in alcohol and drug abuse is expected, further leading to isolated overdosing and posing a striking challenge for drug addicts. Additionally, according to the Centers for Disease Control and Prevention (CDC), 2021, an individual with substance use disorder is expected to be severely ill if infected with the SARS-CoV2 virus. However, as per the research article published in Population Health Management, 2021, a significant decrease in the testing for prescription and illicit drugs was observed, with a weekly test volume decrease of 70%. Hence, there is an increased need for healthcare and public health organizations to be involved in drug abuse testing during the pandemic era to minimize the unfavorable health outcomes among the majority of the global population, and thus, the studied market is expected to be positively impacted during the pandemic era.

The drug abuse testing market is expected to observe good growth due to the increasing demand for drug abuse treatment, stringent laws mandating alcohol and drug testing, rising drug-related mortality, and increasing government initiatives.

The use of drugs was found to give rise to a lot of illegal activities that consume a lot of resources of a country. These aspects have driven the governments of developed and emerging nations to take legal action against addicts and abusers. Therefore, the developed countries like the United States have stringent laws for drug abuse and have mandated alcohol and drug testing. To limit violence or accidents, drug and alcohol testing on the roads is becoming very common in developing and developed countries, which is helping the growth of the overall market. Thus, a growing trend witnessed in the drug abuse testing market is that leading players are enhancing their product portfolios by adding products and updating software with new substances for drug abuse testing to maintain their competency and market shares.

Identifying drug testing strategies is also necessary, as they may lead to the adoption of drug testing kits and devices and thus, boost the market growth. Other factors that are expected to positively affect the growth of this market include the increasing demand for drug addiction treatment, rising drug-related mortality, and growing government initiatives. This market is also currently growing due to technological advancements, increased sensitivity, minimal time required for testing, and facilitated detection of newly developed designer drugs.

Scope of the Report

As per the scope of the report, drug abuse testing is found to be a clinical screening procedure to detect one or more illegal substances like drugs, chemicals, or plant products that patients are addicted to. This clinical screening procedure is performed on the patient's urine, saliva, blood, hair, or sweat. Today's modern lifestyle is pushing adults toward drug abuse, and to help them, the government is promoting DOA testing. The drug abuse testing market is segmented by product type, sample type, end user, and geography. By product type, the market is segmented into analyzers (immunoassay analyzers, chromatographic devices, and breath analyzers), rapid testing devices (urine testing devices and oral fluid testing devices), and consumables. By sample type, the market is segmented into saliva, urine, blood, and other sample types. By end user, the market is segmented into hospitals, diagnostic laboratories, forensic laboratories, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. The report offers the value (USD million) for all the above segments.

By Product Type
Analyzers
Immunoassay Analyzers
Chromatographic Devices
Breath Analyzers
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables
By Sample Type
Saliva
Urine
Blood
Other Sample Types
By End User
Hospitals
Diagnostic Laboratories
Forensic Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Urine Segment is Expected to Dominate Over the Forecast Period

Drug abuse testing by urine analysis has been suggested and implemented in many cases for workplace drug abuse, criminal justice cases, etc. There are many laboratory setups established to perform urinalysis associated with methadone treatment that has had to greatly expand their capacities. In recent years, many new laboratories have sprung up to meet the demands for drug assays, and clinical laboratories associated with medical centers, under economic pressures in recent years, have begun to venture into drug testing. Therefore, the urine analysis segment of the market is expected to gain traction shortly.

Also, the technological developments in drug abuse testing, the increasing number of deaths due to drug overdose, and the growing demand for drug tests have led to the increasing use of urine analysis for drug abuse. Also, the advancements in guidelines by the providers are expected to boost the studied segment. For instance, with effect from April 2020, WellCare Health Plans announced the new Clinical Coverage Guidelines and Claims Payment Policy for urine drug testing and included definitive urine drug testing as medically necessary as part of a routine monitoring program for individuals who receive treatment for chronic pain with prescription opioid or other potentially abused medications or those undergoing treatment for, or monitoring for relapse of, opioid addiction or substance use disorder. Additionally, as per the research article published in the Journal of Applied Laboratory Medicine, 2020, there has been an increased adoption in the targeted panel of urine drug testing, and the value of clinical urine drug testing was observed to have improved by providing laboratory-based results interpretation and consultative services. Thus, owing to the aforementioned factors, the studied segment is expected to witness healthy growth over the forecast period.

Drug Abuse Testing Market 1

North America Holds the Largest Market Share, and it is Expected to do the Same Over the Forecast Period

North America accounts for the largest share in the drug abuse testing market globally. Drug abuse is a serious problem that can lead to legal, financial, and health problems, and the North American region is currently facing the same problems. Therefore, various initiatives are being implemented by the US government to monitor the symptoms and to determine whether a person is under drug abuse. For instance, the Patients and Communities Act of 2018 was a law implemented by the country for counter-acting drug abuse.

There is also high adoption of technologically advanced products for drug abuse testing, increased demand for illicit drugs in the region, large-scale drug trafficking, which are all responsible for the growth of the market in the region. As per the 2018 National Survey on Drug Use and Health report, more than 500,000 adolescents aged 12 to 17 years were suffering from illicit drug use disorder in 2018 in the United States. For adults aged 18 years or above, this number was reported to have increased from 4.6 million in 2017 to 4.9 million in 2018. Additionally, as per the National Highway Traffic Safety Administration’s 2018 report “Traffic Safety Facts”, there were 36,560 fatalities in total due to driving under the influence of alcohol in 2018 in the United States. Additionally, in May 2020, Cannabix Technologies Inc. developed a new version of its THC Breath Analyzer, and it has been involved in developing the device for additional testing. Thus, the rising drug and alcohol abuse and emerging new technologies to detect intoxication in the body are expected to help the market growth in the region over the forecast period.

Drug Abuse Testing Market 2

Competitive Landscape

The drug abuse testing market is moderately competitive. The major players in the drug abuse testing market include Danaher Corporation, Siemens Healthineers AG, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd, Quest Diagnostics Inc., LabCorp, Abbott Laboratories, and Thermo Fisher Scientific Inc., among others. Through strategic alliances such as acquisitions, partnerships, and new product launches, the leading players are attaining competency and larger market shares in the drug abuse testing industry. For instance, in August 2019, Abbott Laboratories partnered with Intoximeters, allowing Intoximeters to market Abbott's SoToxaTM Mobile Test System, which is a handheld oral fluid roadside testing solution that rapidly and reliably detects recent drug use along with Intoximeters' Alco-Sensor brand breath alcohol-testing products.

Recent Developments

In December 2020, Clinical Reference Laboratory (CRL) acquired Confirm BioSciences, which is one of the leading providers of comprehensive screening tools and solutions, aiding in the expansion of Confirm's access to lab testing services and research and development capabilities, which may help CRL due to Confirm's huge customer base in drug abuse testing.

In April 2020, Cordant Health Solutions began a telemedicine-based oral fluid drug testing solution to assist in providing critical care to individuals recovering from substance use disorder.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand for Drug Abuse Treatment

      2. 4.2.2 Stringent Law Mandating Alcohol and Drug Testing

      3. 4.2.3 Rising Drug-related Mortality and Increasing Government Initiatives

    3. 4.3 Market Restraints

      1. 4.3.1 Perception of Drug Abuse Testing as a Violation of Rights

      2. 4.3.2 Lack of Awareness Regarding the Availability of Advanced Drug Testing Devices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Analyzers

        1. 5.1.1.1 Immunoassay Analyzers

        2. 5.1.1.2 Chromatographic Devices

        3. 5.1.1.3 Breath Analyzers

      2. 5.1.2 Rapid Testing Devices

        1. 5.1.2.1 Urine Testing Devices

        2. 5.1.2.2 Oral Fluid Testing Devices

      3. 5.1.3 Consumables

    2. 5.2 By Sample Type

      1. 5.2.1 Saliva

      2. 5.2.2 Urine

      3. 5.2.3 Blood

      4. 5.2.4 Other Sample Types

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Diagnostic Laboratories

      3. 5.3.3 Forensic Laboratories

      4. 5.3.4 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Danaher Corporation (Beckman Coulter)

      3. 6.1.3 LabCorp

      4. 6.1.4 Dragerwerk AG & Co. KGaA

      5. 6.1.5 Quest Diagnostics Inc.

      6. 6.1.6 Randox Testing Services

      7. 6.1.7 United States Drug Testing Laboratories Inc. (USDTL)

      8. 6.1.8 Thermo Fisher Scientific Inc.

      9. 6.1.9 Siemens Healthineers AG

      10. 6.1.10 F. Hoffmann-La Roche Ltd

      11. 6.1.11 Clinical Reference Laboratory Inc.

      12. 6.1.12 Cordant Health Solutions

      13. 6.1.13 Omega Laboratories Inc.

      14. 6.1.14 Psychemedics Corporation

      15. 6.1.15 Precision Diagnostics

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

  8. 8. IMPACT OF COVID-19 ON THE MARKET

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Drug Abuse Testing Market market is studied from 2018 - 2026.

The Drug Abuse Testing Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Danaher Corporation (Beckman Coulter, Inc.), Quest Diagnostics Inc., LabCorp, Drägerwerk AG & Co. KGaA, Abbott Laboratories are the major companies operating in Drug Abuse Testing Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!